ebook Munafa Stock Market Course + Intraday & FNO calls  

       

500660 announcements Glaxosmith announcements and dividends declared BSE

Glaxosmith Complete list of announcements declared & dividend announcements by Glaxosmith 500660

Glaxosmith 500660 listed on BSE and deals in

Announcements and dividends declared by Glaxosmith 500660

Sanofi-GlaxoSmithKline's experimental Covid vaccine fails in some older patients
Instead, the companies said they planned to test a modified version of their vaccine in a smaller trial beginning in February. Rather than compare their candidate with a placebo, they said, it could be tested against a vaccine expected to be authorized by
Announcement as on 11 December 2020

GlaxoSmithKline Pharma Q2 net profit declines 85% to Rs 76.47 crore
Drug firm GlaxoSmithKline Pharmaceuticals on Wednesday reported nearly 85 per cent decline in its consolidated net profit to Rs 76.47 crore for the quarter ended in September. The company had posted a net profit of Rs 502.75 crore for the corresponding per
Announcement as on 29 October 2020

GlaxoSmithKline Pharma Q2 results: Net profit declines 85% to Rs 76 cr
Consolidated revenue from operations of the company stood at Rs 879.32 crore for the quarter under consideration. It was Rs 882.02 crore for the same period a year ago, it added.
Announcement as on 28 October 2020

Sanofi, GlaxoSmithKline signs deal with Canada to deliver 72 million doses of potential COVID-19 vaccine
Sanofi and GlaxoSmithKline PLC announced Tuesday that the companies have signed agreements with Canada to supply up to 72 million doses of their COVID-19 vaccine, starting in 2021. The companies had initiated a Phase 1/2 study on their vaccine candida
Announcement as on 22 September 2020

Announcements by Glaxosmith first page | Prev page |

500660 Glaxosmith current price & indicator signals

Moving Averages for Glaxosmith

  • 5Day Average: 2304.8
  • 12Day Average: 2338.4
  • 20Day Average: 2394.14
  • 50Day Average: 2463.18
  • 100Day Average: 2475.52
  • 150Day Average: 2562.25
  • 200Day Average: 2695.02

500660 Indicators & signals

Indicator MACD (12,26,9)

2346.54, 2401.84, -50.36
Indicator MACD is in negative zone

Indicator ADX (14)

15.57, 16.81, 23.01
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 41
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 500660 Glaxosmith are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
06 Mon Apr 2026 2346.65 2267.35 to 2351.95 1.57% 0.63 times
02 Thu Apr 2026 2310.45 2262.00 to 2315.40 -0.6% 0.8 times
01 Wed Apr 2026 2324.30 2292.15 to 2402.45 1.79% 1.71 times
30 Mon Mar 2026 2283.40 2218.00 to 2394.85 1.07% 1.44 times
27 Fri Mar 2026 2259.20 2257.10 to 2325.90 -2.69% 1.08 times
25 Wed Mar 2026 2321.60 2308.00 to 2350.10 0.59% 0.57 times
24 Tue Mar 2026 2308.00 2285.50 to 2338.65 1.23% 1.04 times
23 Mon Mar 2026 2279.85 2269.05 to 2357.40 -4.24% 0.76 times
20 Fri Mar 2026 2380.90 2365.65 to 2415.00 0.14% 1.61 times
19 Thu Mar 2026 2377.65 2372.50 to 2421.35 -2.36% 0.42 times
18 Wed Mar 2026 2435.10 2431.70 to 2470.95 0.06% 0.57 times
17 Tue Mar 2026 2433.65 2398.00 to 2439.95 1.18% 0.57 times

Videos related to: 500660 announcements Glaxosmith announcements and dividends declared BSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

500660 announcements Glaxosmith announcements and dividends declared BSE

 

Back to top